Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.150
-0.010 (-0.32%)
At close: Jul 1, 2025, 4:00 PM
3.100
-0.050 (-1.59%)
After-hours: Jul 1, 2025, 6:00 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $33.97 million as of July 1, 2025. Its market cap has decreased by -44.11% in one year.
Market Cap
33.97M
Enterprise Value
14.45M
1-Year Change
-44.11%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $33.97M, an increase of 12.01%. That is a compound annual growth rate of 2.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 34.08M | -0.94% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |